Search
for
Sort by
Research 211–240 of 1000+
- Dermatologic therapy: December 1987 to December 1988
- Dermatologic therapy: December 1986 to December 1987
- Efficacy and safety of combined topical ethinylestradiol with minoxidil versus topical minoxidil in female pattern hair loss. A trichoscopic randomized controlled clinical study
- 1428 DKK2 and SOSTDC1 cooperate to initiate the first catagen phase of the hair follicle growth cycle
- 1386 Estetrol prolongs anagen in healthy female scalp hair follicles by positively modulating dermal papilla functions and generation of progenitor stem cells ex vivo
- 11 Plasma-Rich Protein and ACell
- 13. Wound Healing
- 174 Changes in urine androgen and PG levels during finasteride treatment
- Combination of a non-ablative 1,927 nm thulium fiber fractional laser and autologous platelet-rich plasma in treatment of male androgenetic alopecia: A pilot study
- Symposium 6-4 (SYP 6-4) : Recent progress in the treatment of male pattern hair loss: Lasers and devices
- The involvement of ROS on androgen inducible TGF beta 1 regulation derived from dermal papilla cells; a suggestive implication of ROS on androgenetic alopecia
- 072 Covid-19 and male androgenetic alopecia: Systematic investigation of a potential epidemiological and genetic association
- 1381 Molecular mechanisms of donor dominance in androgenetic alopecia
- Dynamic expression patterns of tenascin, proteoglycans, and cell adhesion molecules during human hair follicle morphogenesis
- 0439 Temporal–phenotype signatures of alopecia associated with GLP-1–based therapies: A PRISMA-ScR scoping review
- Cutaneous signs in COVID ‐19 patients: A review
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Association of androgenetic alopecia with metabolic syndrome: A case–control study on 100 patients in a tertiary care hospital in South India
- Finasteride reduces serum PSA to a similar extent at 1 mg and 5 mg daily doses
- Androgen sensitivity gateway to COVID‐19 disease severity
- Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?
- Polycystic Ovaries Are Inherited as an Autosomal Dominant Trait: Analysis of 29 Polycystic Ovary Syndrome and 10 Control Families
- Permanent Alopecia After Systemic Chemotherapy: A Clinicopathological Study of 10 Cases
- No Association between Serum Ferritin Levels >10 μg/l and Hair Loss Activity in Women
- Male androgenetic alopecia: Population-based study in 1,005 subjects
- 5‐alpha‐reductase inhibitors are associated with reduced frequency of COVID‐19 symptoms in males with androgenetic alopecia
- Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients
- Unilateral Gynecomastia Induced by Treatment With 1 mg of Oral Finasteride
- What can the hair tell us about COVID‐19?